M. Moscariello

Active hospital-based surveillance of invasive pneumococcal disease and clinical pneumonia in infants and young children in two Polish counties

J. Wysocki, W. Służewski, E. Gutterman, 2016, Archives of medical science : AMS.

Prospective Surveillance Study of Invasive Pneumococcal Disease Among Urban Children in the Philippines

P. Kilgore, M. R. Capeding, S. A. Kim, 2013, The Pediatric infectious disease journal.

Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis.

B. Sands, G. Chan, C. Nduaka, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.

B. Sands, G. D'Haens, G. Chan, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hospital-based surveillance of invasive pneumococcal disease and pneumonia in South Bangalore, India

Shivananda, P. Kilgore, A. Gopi, 2015, Indian Pediatrics.

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

S. Vermeire, P. Higgins, B. Sands, 2017, Gut.

Long-term Immune Responses to Pneumococcal Conjugate Vaccines in Children Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

N. Klein, P. Mcgovern, R. Northington, 2013, The Pediatric infectious disease journal.

Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study

P. Higgins, G. D'Haens, G. Chan, 2017, Alimentary pharmacology & therapeutics.

Long-Term Safety and Tolerability of Oral Tofacitinib in Patients with Crohn’s Disease: Results from a Phase 2 Open-Label 48-Week Extension Study

P. Higgins, G. D'Haens, G. Chan, 2017 .

P684 The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: updated results from the tofacitinib ulcerative colitis clinical programme

B. Sands, G. Chan, C. Nduaka, 2018, Journal of Crohn's and Colitis.